Skip to content

Effects of a noisy galvanic vestibular stimulation on the vestibulospinal reflex threshold in patients with bilateral vestibulopathy

Effects of a noisy galvanic vestibular stimulation on the vestibulospinal reflex threshold in patients with bilateral vestibulopathy - BVPGVS

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00013242
Enrollment
10
Registered
2017-10-26
Start date
2017-10-30
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

H81.8

Interventions

Group 1: White noise galvanic vestibular stimulation (GVS) at an intensity of 80% of the individual cutaneous threshold for GVS. GVS is applied for the whole duration of the reflex threshold testing (

Sponsors

German Center for Vertigo and Balance Disorders, Ludwig-Maximilians-University Munich
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Neurological approved bilateral vestibulopathy

Exclusion criteria

Exclusion criteria: Auditory, neurological, cardiovascular or orthopedic diseases

Design outcomes

Primary

MeasureTime frame
Change in the vestibulospinal reflex threshold. The reflex threshold will be determined by a psychometric test procedure. Accordingly, the vestibulospinal reflex responses (trunk movements) to a vestibular stimulus (sinusoidal galvanic vestibular stimulation (1 Hz)) at varying amplitudes (0 to 1.9 mA) will be measured (by means of motion sensors attached to the forehead and chest) and the smallest stimulus amplitude that elicits a reflex response will be psychometrically determined. This amplitude will be defined as the vestibulospinal reflex threshold. The threshold test lasts for ~ 5 minutes.

Countries

Germany

Contacts

Public ContactRoman Schniepp

Department of Neurology & German Center for Vertigo and Balance Disorders, Ludwig-Maximilians-University Munich

Roman.Schniepp@med.uni-muenchen.de0049 (0)89 4400 72486

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026